# Hybrid Closed-Loop System in LADA Patients: A Randomized Trial

> **NCT06941675** · NA · RECRUITING · sponsor: **Shanxi Bethune Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Latent Autoimmune Diabetes in Adults (LADA)

## Interventions

- **OTHER:** Hybrid Closed-Loop Artificial Pancreas System

## Key facts

- **NCT ID:** NCT06941675
- **Lead sponsor:** Shanxi Bethune Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-08-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06941675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06941675, "Hybrid Closed-Loop System in LADA Patients: A Randomized Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06941675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*